Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir (SPARE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by National Center for Global Health and Medicine, Japan.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Ministry of Health, Labour and Welfare, Japan
Information provided by (Responsible Party):
National Center for Global Health and Medicine, Japan
ClinicalTrials.gov Identifier:
NCT01294761
First received: February 10, 2011
Last updated: January 16, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
No publications provided by National Center for Global Health and Medicine, Japan

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):